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ABSTRACT 
The antimitotic compound methyl benzimidazol-2-yl carbamate (MBC) formed a 
complex in vitro with a protein present in mycelial extracts of fungi.  The binding 
protein  of Aspergillus nidulans showed  a  set  of properties  which  is unique  for 
tubulin. Binding occurred rapidly at 4~  and was competitively inhibited by oncoda- 
zole and colchicine. Other inhibitors of microtubule function such as podophyllo- 
toxin, vinblastine sulfate, melatonin, and griseofulvin did not interfere with binding 
of MBC. Electrophoretic analysis of partially purified preparations of the binding 
protein  revealed the  presence  of proteins  with similar  mobilities as mammalian 
tubulin monomers. Hence it is concluded that the binding protein is identical with 
fungal tubulin. 
The effect of MBC on mycelial growth of mutant strains  of A. nidulans was 
positively correlated with the affinity  of the binding sites for this compound. The 
apparent binding constant for MBC and tubulin from a wild type was estimated at 
4.5  x  10  5, from a resistant strain at 3.7  x  10  4, and from a strain with increased 
sensitivity to MBC at  1.6  x  l0  s liters/mol.  Mutants showing resistance and in- 
creased sensitivity to MBC are candidates to have alterations in tubulin structure. 
affinity  of tubulin for MBC is probably a common mechanism of resistance to this 
to this compound in fungi. 
Low affinity of tubulin for MBC is probably a common mechanism of resistance 
binding constant of 2.5  x  10  a liters/mol. 
In  the  last  15  years  several  benzimidazole com- 
pounds  have  been  introduced  as  fungicides,  like 
benomyP (29),  fuberidazole (58),  and thiabenda- 
1The  following common names and abbreviations  are 
used: benomyl, methyl 1-(butylcarbamoyl)benzimidazol- 
2-yl carbamate; fuberidazole,  2-(2'-furyl)benzimidazole; 
thiabendazole,  2-(4'-thiazolyl)  benzimidazole;  fenbenda- 
zole (66),  as anthelmintics, like fenbendazole (5), 
mebendazole (68), parbendazole (1), and thiaben- 
zole,  methyl 5-phenylthiobenzimidazol-2-yl  carbamate; 
mebendazole, methyl 5-benzoylbenzimidazoi-2-yl carba- 
mate;  parbendazole,  methyl  5-butylbenzimidazol-2-yl 
carbamate; oncodazole or R 17934, methyl 5-(2-thienyl- 
carbonyl)benzimidazol-2-yl  carbamate; carbendazim or 
MBC,  methyl benzimidazol-2-yl  carbamate;  SDS,  so- 
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Structural formulas  of biologically  active  benzimidazole  compounds. 
dazole (12), or as antitumoral drug, like oncodazole 
or R  17934  (3,  4).  Structural  formulas of these 
compounds are shown in Fig. 1. 
In recent years considerable attention has been 
given to  the  mechanism  of action  of these  com- 
pounds. Benomyl and its conversion product, car- 
bendazim or methyl benzimidazol-2-yl carbamate 
(MBC), interfere with mitosis in fungi (21, 39, 56), 
plants (56), and mammalian cells in vivo (59, 67) 
and  in  vitro  (27,  59,  67).  Mebendazole  induces 
degenerative changes in intestinal  cells of parasites 
after treatment of their hosts (8). These effects are 
probably caused by the interaction of this drug with 
cytoplasmic microtubules (9,  10).  Oncodazole in- 
terferes with the structure and function of microtu- 
bules  both  in  interphase  and  mitotic mammalian 
dium dodecyl sulfate; PKMg buffer, 0.05 M potassium 
phosphate  buffer, pH 6.8,  containing 0.1  M KC1 and 
0.005  M  MgC12; DMSO,  dimethylsulfoxide; PNaMg 
buffer, 0.05 M sodium phosphate buffer, pH 6.8, con- 
taining 0.1 M NaC1, and 0.005 M MgC12; MES, 2-(N- 
morpholino)ethane sulfonic acid; EGTA, ethyleneglycol- 
bis-(fl-aminoethylether)tetraacetic  acid;  TEMED, 
N,N,N',N' ,-tetramethylenediamine. 
cells  cultured  in  vitro  (25,  26).  Microtubules  of 
dividing and nondividing malignant cells in vivo are 
similarly  affected (26). 
Although  the  biological activity  of these  benz- 
imidazole compounds is probably based on interfer- 
ence with the formation or functioning of microtu- 
bules,  which  are  present  in  all  eukaryotic  cells, 
eukaryotes are not equally sensitive to each benz- 
imidazole compound.  Benomyl and MBC partly 
owe their success as systemic fungicides to a relative 
nontoxicity to plants and animals. But also within 
fungi, there  are  differences in sensitivity  to these 
compounds.  For instance,  fungi belonging to the 
Ascomycetes  are  sensitive,  whereas  others  be- 
longing  to  the  Oomycetes  are  resistant  (7).  In 
addition  to  natural  resistance  to  benomyl  and 
MBC, resistant strains of naturally sensitive spe- 
cies are frequently found in sprayed crops. In the 
laboratory such strains can be readily obtained by 
mutagenic treatment (28). 
The curative action of mebendazole in animal as 
well as in human helminthiases implies selectivity 
with respect to host and parasite.  Ultrastructural 
studies  have  shown  that  upon  treatment  of the 
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pletely destroyed,  whereas cytoplasmic and spin- 
dle  microtubules of  the  host  cells  remain  unaf- 
fected, even though both types of cells have been 
exposed to identical drug concentrations (9,  10). 
In vivo experiments on the effect of oncodazole 
on  experimental  and  human  neoplasms  have 
shown that this compound specifically eliminates 
microtubules in dividing and nondividing neoplas- 
tic cells, whereas microtubules of interphase nor- 
mal  cells  are  apparently  intact.  Microtubules in 
mitotic cells, however, are seriously affected (26). 
Biochemical studies on the mechanism of action 
of benzimidazole compounds have shown that the 
antimitotic action  of  MBC  in  fungi is  probably 
mediated via binding to fungal tubulin (22,  23). 
Oncodazole is bound to mammalian brain tubulin 
at the colchicine-binding site (45) and is a potent 
inhibitor of microtubule assembly in vitro (26, 27, 
45).  Benomyl and MBC  only slightly affect  this 
process (27, 44). 
The molecular basis of selectivity of these benz- 
imidazole compounds is yet unknown. Differen- 
tial uptake or metabolism may be responsible for 
the relative nontoxicity of benomyl and MBC to 
animals and plants (36,  65).  For natural and in- 
duced resistance in fungi, it has been found that no 
differences  in  metabolism  exist  between  MBC- 
resistant and MBC-sensitive strains (24).  Here  a 
differential binding of MBC to tubulin in strains 
differing  in  MBC  sensitivity might  underly  the 
selective action of this compound (22,  23).  The 
selective action of mebendazole does not appear 
to be related to a differential drug uptake between 
host and parasite  (9,  10).  A  differential interac- 
tion of the drug with the target inside the cells is 
assumed to be responsible (9, 10). 
In this study the  interaction of MBC  with  its 
receptor site in MBC-sensitive and MBC-resistant 
strains of the fungus Aspergillus  nidulans  has been 
investigated in detail. Since it has been assumed 
that  MBC  binds to  fungal tubulin the  effect  of 
oncodazole and of other inhibitors of microtubule 
function on MBC binding has been studied. With 
[14C]MBC  as  affinity label,  the  binding protein 
was partially purified and electrophoretically char- 
acterized. 
MATERIALS  AND  METHODS 
Organisms 
Most of the  experiments were  carded  out with A. 
nidulans biA1 AcrA1 (strain 003) and two mutant strains 
(strains 186 and R), which differ in MBC sensitivity. The 
sensitivity of these strains, in terms of inhibitory concen- 
trations which cause a 50% reduction in growth (mean 
inhibitory dose, IDs0) on agar, is 4.5 t~M MBC for strain 
003, 1.5  /xM for strain 186, and 95  /~M for strain R. 
Both strains were  selected  in the laboratory after UV 
treatment of conidia of strain 003 (69). Genetic analysis 
has shown that both increased sensitivity in strain 186 
and resistance to MBC in strain R had been caused by a 
mutation in one single gene, located on linkage group 
VIII (69, 70). 
We  also  used  MBC-sensitive  strains of Penicillium 
brevicompaetum and P. corymbiferum as well as resistant 
strains of these  fungi, which emerged in MBC-treated 
crops  (6). Alternaria brassicae and Pythium irregulare 
represented the naturally MBC-resistant fungi. 
Culture Methods 
Conidia of A. nidulans strains were  grown on a 2% 
malt extract, 0.1%  bacto-peptone, 2%  glucose,  1.5% 
agar medium. Conidial suspensions  were  prepared  as 
described  previously (21). Conidia of Penicillia strains 
and A. brassicae were  harvested fi'om potato-dextrose 
agar and oatmeal agar,  respectively.  P.  irregulare was 
maintained on  potato-dextrose  agar.  Mycelium of A. 
nidulans strains was grown in a glucose-nitrate  medium 
(57), supplemented with 1 ~g biotin per ml. Mycelium 
of the other fungi were  cultured in Czapek-Dox liquid 
medium (Oxoid, Oxoid Ltd., London, England), supple- 
mented  with  0.5%  (wt/vol)  yeast  extract  powder 
(Oxoid).  Cultures  were  incubated on  a  Gallenkamp 
orbital shaker  (Gallenkamp &  Co.  Ltd.,  London) at 
200 rpm at 37~  for A. nidulans and at 25~  for the 
other fungi. 
Preparation of Mycelial Extracts 
Exponentially growing  mycelium was  harvested  by 
filtering on a B6chner filter. The mycelium was washed 
three times in cold 0.05 M potassium phosphate buffer, 
pH 6.8, and frozen at -22~  in a previously cooled X- 
Press  Cell Disintegrator (LKB Produkter, Stockholm, 
Sweden) with 0.5 ml of homogenization  buffer per g wet 
weight  of mycelium. The homogenization buffer con- 
sisted  of 0.05 M potassium phosphate buffer, pH 6.8, 
containing 0.1 M KCI and 0.005 M MgClz (PKMg solu- 
tion). After 1 h at -22"C the mycelium was homoge- 
nized by passing  it five  times through the  press.  The 
homogenate was  thawed  and then guanosine triphos- 
phate (GTP) was added to a final concentration of 0.1 
raM. The suspension was centrifuged at 40,000 g for 10 
min and the resultant supemate recentrifuged at 48,000 
g for 30 re.in. The 48,000-g supernate was immediately 
used in binding studies.  All steps were done at 4~ 
Preparation of Porcine Brain Extracts 
Fresh  porcine  brains were  obtained from  Stroom- 
berg's Exportslachterij  (Ede, The Netherlands) and ira- 
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ninges were  removed and the tissue was washed three 
times with ice cold 0.05 M potassium phosphate buffer, 
pH 6.8, and once with PKMg solution. 100 g of tissue 
was then homogenized with 100 ml of PKMg solution, 
containing 0.1  mM  GTP,  using  a  motor-driven glass 
homogenizer with Teflon pestle (B. Braun Apparatebau, 
Melsungen,  Germany).  The  homogenate  was  centri- 
fuged at 48,000 g for 60 min and the resulting supernate 
was fractionated with a neutralized saturated ammonium 
sulfate solution. The fraction precipitating between 35 
and 50% saturation was taken up in 10 ml PKMg solu- 
tion containing 1 mM GTP. This preparation was used in 
binding assays either directly or after storage at -22~ 
Binding Assays 
Varying  amounts  of  a  methanolic  solution  of 
[14C]MBC were added to mycelial or brain extracts and 
incubated either at 4  ~ or  37"C for various periods  as 
specified in the legend of figures and tables. Small sam- 
ples of a [aH]colchicine solution in benzene/ethanol (9/1) 
were  placed  in  empty  scintillation vials or  centrifuge 
tubes and the  solvent was evaporated to  dryness in a 
stream of nitrogen. The dried compound was dissolved 
directly in mycelial or porcine brain extract. Vials and 
tubes were wrapped in aluminum foil to prevent photo- 
decomposition  of  colchicine.  Incubation was  at  4 ~ or 
37~  for various periods as specified. Potential inhibitors 
of MBC binding were added as solutions in dimethylsulf- 
oxide  (DMSO).  The  DMSO  concentration of treated 
and control samples never exceeded 0.1% vol/vol. 
Binding of [~4C]MBC or [aH]colchicine  was measured 
by gel filtration of 1 ml of the incubation mixture on a 
Sephadex  G-100  column  (28  x  1.5  cm)  with PKMg 
solution as elution buffer. Fractions of 16 drops (approx- 
imately  1  ml)  were  collected  with  a  LKB  UItroRac 
fraction collector, and radioactivity in each fraction was 
measured in a Nuclear-Chicago Mark I Liquid Scintilla- 
tion Spectrometer (Nuclear-Chicago Corp., Des Haines, 
Ill.) with Bruno and Christian's (13) scintillation liquid. 
Counting efficiency was determined by external stand- 
ardization procedures.  Radioactivity present in protein 
fractions was considered to represent bound ligand. 
Binding of [14C]MBC was also measured with a  sec- 
ond  method,  which  has  been  introduced  recently  to 
measure colchicine binding to tubulin (62, 63). Aliquots 
of the incubation mixture were placed in centrifuge tubes 
containing an  equal  volume  of  a  charcoal  suspension 
(Merck A. G. Inc., Darmstadt, West Germany) at 6 rag/ 
ml in PKMg solution. The tubes were placed in a shaker 
and the mixture was heavily agitated for 10 rain and then 
centrifuged at 1,500 g for 5 rain at 40C. Aliquots of the 
supernate were assayed for radioactivity. Blanks, which 
contained 40  mg/ml bovine  serum albumin in  PKMg 
solution incubated with [~4C]MBC were handled in the 
same  way.  The  difference  in  amount  of  radioactivity 
found in supernatant aliquots of sample and blank was 
assumed  to  represent bound  [14C]MBC.  Bound  MBC 
was expressed as disintegrations per minute per unit of 
volume of the original extract. 
Purification of Fungal Tubulin 
Mycelial extracts were prepared as described above, 
but with 0.05 M sodium phosphate, pH 6.8, containing 
0.1  M  NaC1  and  0.005  MgCI~ (PNaMg  solution)  as 
homogenization buffer. The 48,000-g supernatant myce- 
lial extract was further centrifuged at 127,000 g  for 60 
min. The soluble proteins were fractionated with a neu- 
tralized (pH 6.8  after 20:1  dilution) saturated ammo- 
nium sulfate solution. The fraction precipitating between 
35 and 50% saturation was taken up in PNaMg solution 
containing 1 mM GTP. 
The  resulting  preparations  were  incubated  with 
[~4C]MBC and run onto a  DEAE-Sephadex A-50 col- 
umn (10  x  1.5 cm), which had been previously equili- 
brated with PNaMg  solution. The  column  was  subse- 
quently eluted with 15 ml of a linear gradient of 0.1-0.4 
M NaCI, 15 ml of 0.4 M NaC1, 30 ml of a linear gradient 
of 0.4-1.0 M  NaC1,  and 20 ml of 1.0 M  NaCI, respec- 
tively, all made up in buffer. Gradients were produced 
by a LKB Ultrograd Gradient Mixer (LKB Produkter). 
The eluate was continuously monitored at 254 nm and 
fractions of constant volume were collected. Radioactiv- 
ity was measured in each fraction. 
Once the elution properties of the MBC complex were 
established, the incubation step was omitted and the 35- 
50% ammonium sulfate preparation was applied directly 
to the DEAE-Sephadex column. Fractions which were 
eluted at 0.45-0.90 M  NaCI, were combined, dialyzed 
against bidistilled water,  and lyophilized. Dry samples 
were stored at -22~  above silica gel until analysis. 
Purification of Porcine Brain  Tubulin 
Two purification methods were  used.  With the first 
method,  a  tubulin preparation  prepared  as  described 
above, but with PNaMg solution as extraction buffer, 
was  chromatographed  onto  a  DEAE-Sephadex  A-50 
column in the same way as described above for mycelial 
extracts.  Fractions  containing  tubulin  were  dialyzed 
against  bidistilled water  and  lyophilized.  The  second 
method used was a slightly modified assembly-disassem- 
bly procedure according to Shelanski et al. (61). Fresh 
porcine brains were washed and homogenized in 0.1 M 
2-(N-morpholino)ethane sulfonic acid (MES) buffer, pH 
6.90, containing 1 mM EDTA, 0.1  mM GTP, and 0.5 
mM MgCI2 (MES buffer). The homogenate was centri- 
fuged at 40,000 g for 10 min and the resulting supemate 
at 48,000 g  for 60 min at 4~  To achieve assembly of 
microtubules extracts were mixed with an equal volume 
of MES buffer containing 8 M glycerol and 2 mM GTP 
and incubated for 30 min at 37~  Assembled microtu- 
bules were pelleted by centrifuging at 48,000 g at 25~ 
After  resuspension  and  depolymerization  of  microtu- 
bules in MES buffer at 4~  and centrifuging, a  second 
assembly cycle was performed. 
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MBC-Protein Complex 
The molecular weight of the MBC-protein complex 
was determined by gel filtration of an ammonium sulfate 
fractionated mycelial extract, which had been incubated 
with [~4C]MBC on a Sephadex G-200 column (2.5  x  32 
cm),  according  to  the  method  of  Andrews  (2).  The 
column was calibrated in two parallel runs with alcohol 
dehydrogenase (yeast), mol wt 150,000 and cytochrome 
c  (horse  heart),  mol  wt  12,400;  and  with  lipoamide 
dehydrogenase (pig heart), mol wt 100,000 and a-chy- 
motrypsin (beef pancreas), mol wt 24,500, respectively. 
Reduction and Carboxymethylation 
of Proteins 
Proteins were reduced by adding/3-mercaptoethanol 
and sodium dodecyl sulfate (SDS) at final concentrations 
of 1% to the samples and heating for 2 rain at 100~ 
The reduced proteins were dialyzed overnight at room 
temperature against 0.01  M  sodium phosphate buffer, 
pH 7.0, containing 0.1%  /3-mercaptoethanol and 0.1% 
SDS. 
Protein samples were reduced and carboxymethylated 
according  to  the  method  of  Crestfield  et  al.  (20)  as 
modified by Renaud et al. (55). Protein solutions were 
made 1% in/3-mercaptoethanol and mixed with an equal 
volume of reducing solution (0.35 M Tris-HCl, pH 8.8, 
containing 0.12 M  fl-mercaptoethanol, 8  M  urea,  and 
0.1%  EDTA).  The mixture was dialyzed overnight at 
room temperature against this solution. Lyophilized pro- 
teins were  directly  dissolved in reducing solution and 
incubated overnight at room temperature under nitro- 
gen. The reduced proteins were carboxymethylated by 
adding one volume of a  1.1-M iodoacetic acid-8 M urea 
solution  in  2.5  N  NaOH  to  nine  volumes of protein 
solution. The reaction was allowed to proceed for 1 h in 
the dark, and the solution was then dialyzed against 0.01 
M Tris-HCl, pH 8.0, for at least 6 h at room temperature 
also in the dark. 
SDS-Polyacrylamide Gel Electrophoresis 
Two SDS systems were employed. The first one was 
based on that of Weber and Osborn (71). Reduced or 
carboxymethylated protein samples were  run on 6-cm 
gels (7.5% [wt/vol] acrylamide, 0.13% [wt/vol] bisacryl- 
amide, 0.075%  [wt/vol]  ammonium persulfate, 0.075% 
[vol/vol] N,N,N',N',-tetramethylenediamine [TEMED] 
in 0.1  M sodium phosphate buffer, pH 7.0) at 40 V for 
about 6 h. The second system was similar to the discon- 
tinuous SDS system as has been described by Luduena 
and Woodward (51).  Carboxymethylated protein sam- 
ples were prepared for electrophoresis as described and 
run on 9-cm gels at 4 mA per gel for approximately 2.5 
h. 
Gels  were  stained for  15  h  in  0.015%  Coomassie 
Brilliant Blue in methanol/acetic acid/water (45/9/46). 
Destaining was  performed  by  diffusion  in  methanol/ 
acetic acid/water (2/3/35). 
Protein  Determination 
Protein was determined according to the method of 
Lowry  et  al.  (50)  as  modified  by  Hartree  (40)  with 
bovine serum albumin as a standard. 
Chemicals 
[2-14C]MBC (sp act 11.4 mCi/mmol) was purchased 
from  International  Chemical  &  Nuclear  Corp.  (Bur- 
bank, Calif.). Stock solutions were prepared in methanol 
at approximately 1,200 p.M  [14C]MBC. Radiochemical 
purity of the preparation was checked at intervals by thin- 
layer silica gel chromatography on DC-Alufolie 60 F 254 
(Merck,  A.  G.,  Inc.) with ethylacetate saturated with 
0.05 M potassium phosphate buffer, pH 6.8, as solvent. 
Chromatograms were  scanned with a  Nuclear-Chicago 
Actigraph  III  radiochromatography  system  (Nuclear- 
Chicago Corp.) and then cut transversely into 1-cm sec- 
tions, which were placed in scintillation vials containing 
Bruno and Christian's scintillation liquid and counted. 
Purity was always found higher than 97%. 
[Ring C-methoxyl-3H]colchicine (sp act 3.8 Ci/mmol) 
as a solution in benzene/ethanol (9/1) was obtained from 
New  England Nuclear  (Boston,  Mass.).  The  prepara- 
tion, diluted to a sp act of 20-200 mCi/mmol, was used 
either as such, or after being purified according to the 
procedure described below. 
Methyl  5-(2-thienyl carbonyl)benzimidazol-2-yl car- 
bamate (oncodazole or R 17934) was a gift of Dr. M. De 
Brabander (Janssen Pharmaceutica, Beerse,  Belgium). 
Colchicine was purchased from Merck A. G., Inc. Gri- 
seofulvin  and  vinblastine sulfate  were  obtained  from 
Sigma Chemical Co.,  (St. Louis, Mo.).  Melatonin and 
podophyllotoxin  were  purchased  from  Fluka  A.  G. 
(Basel, Switzerland) and Aldrich Chemical Co. (Milwau- 
kee, Wis.), respectively. 
Purification  o  f  [3H]  Colchicine 
An aliquot of the [aH]colchicine  solution in benzene/ 
ethanol was diluted with unlabeled colchicine in the same 
solution, giving a concentration of 10 -4 M colchicine at 
approximately 10  a dpm per 100 p.1 solution. 200 txl of 
this solution was applied as a small band to a  silica gel 
plate (DC-Alufolie 60 F  254, Merck A. G.,  Inc.) and 
chromatographed  in  chloroform/acetone/diethylamine 
(5/4/1) over a distance of 17 cm with unlabeled colchi- 
cine as a reference. The center part of the [aH]colchicine 
band (visible under UV at 254 nm) with an Rr value of 
0.57  and  a  1-cm broad band corresponding to  the Ry 
value of an unknown radiolabeled compound X, which 
was found to be present in our colchicine preparation, 
with an Rf value of 0.46 was cut out and transferred to a 
centrifuge tube. The silica gel was scraped off and subse- 
quently eluted four times with 1 ml methanol. To avoid 
photodecomposition  of  the  compounds,  exposure  of 
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procedure.  Tubes and the  chromatography tank were 
wrapped in aluminum foil. Approximately 1.3  x  10  ~ 
dpm were recovered in [aH]colchicine and  1.4  x  10  ~ 
dpm in compound X. To analyze the purified prepara- 
tions, aliquots were spotted onto a chromatogram and 
developed with the same solvent as used before. Chro- 
matograms  were cut  transversely into  1-cm sections 
which were placed in scintillation  vials containing Bruno 
and Christian's scintillation  liquid and counted. Radioac- 
tivity present in sections corresponding to the Re values 
of colchicine  and compound X was 86 and 84%, respec- 
tively of the total radioactivity recovered. In the case of 
[aH]colchicine 11% of the radioactivity was present in a 
third compound with an R  e value of 0.83.  This com- 
pound is probably identical to that found by Borisy and 
Taylor  (11),  which was  shown to  be  formed  during 
storage of [3H]colchicine preparations purified by silica 
gel chromatography. 
RESULTS 
Evaluation of the Charcoal Assay 
In  addition  to  the  gel  filtration  method  for 
measuring MBC  binding, in this work  a  second 
method was used, which is based on separation of 
free  MBC  from  bound MBC  by  adsorption  to 
charcoal. This method was developed because it is 
rapid and suitable for multiple determinations. 
Activated charcoal appeared to be very effec- 
tive in adsorbing free MBC in solutions of bovine 
serum albumin  at 40 mg/ml in PKMg buffer. More 
than  99.5%  of  the  amount of  MBC  could  be 
removed from the solution, when the compound 
was initially present in concentrations up to  40 
/xM.  In mycelial extracts  incubated with  MBC, 
however, removal of free MBC may not involve 
removal of bound MBC. Therefore the charcoal 
assay was compared with the gel filtration method. 
The amount of bound MBC as determined with 
the  charcoal  assay was  about  one  and  one-half 
times as high as that found with the gel filtration 
method. Since incubation  of mycelial extracts with 
[14C]MBC in the presence of a specific inhibitor of 
MBC  binding (see  below)  resulted  in complete 
adsorption of radioactivity to charcoal, the higher 
degree of binding  found with the charcoal assay, is 
not due to incomplete adsorption of free MBC to 
charcoal in mycelial extracts. Hence, less dissocia- 
tion of MBC from the complex during the char- 
coal assay than during the gel filtration procedure 
is probably responsible for this phenomenon. 
Due to dissociation the  value of bound MBC 
decreases with the length of the incubation period 
with charcoal (Fig. 2). In the standard procedure 
mixtures were shaken for 10 min with charcoal, so 
that disturbance of equilibrium was minimum and 
removal of free MBC was maximum. 
Selectivity  of MBC Binding 
MBC binding was found in 48,000-g superna- 
rant extracts of mycelial homogenates in PKMg 
solution after  the  extracts  were  incubated with 
[~4C]MBC at  4~  (22,  23).  Binding activity ap- 
peared  to  be  correlated  with  the  in vivo MBC 
sensitivity of the species or strain examined. Table 
I  gives detailed  binding data  obtained with  the 
Sephadex G-100 assay for various MBC-sensitive 
and  MBC-resistant  fungal  species  or  strains. 
Whereas  extracts  of  sensitive  strains  did  bind 
MBC  in quantities between  3  and  18%  of the 
quantity added, resistant strains did not bind more 
than 0.6% of this amount which is hardly above 
background. 
Since it has been suggested  (22,  23)  that the 
MBC-binding substance is  identical with  fungal 
tubulin, the MBC-binding properties of mamma- 
lian brain tubulin were investigated. Native por- 
cine  brain tubulin, partially purified by  ammo- 
nium sulfate fractionation, did not bind MBC in 
significant amounts at 4  or 37~  indicating that 
mammalian tubulin  has no or at least a low affinity 
for MBC. This is in agreement with the observa- 
tion that MBC at a concentration which is lethal 
~, 2'0 1 
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FIGURE  2 
\ 
1'0  1  =5  ~0 
Time  (rain) 
Effect of incubation time during the  char- 
coal assay on the quantity of bound MBC. A mycelial 
extract ofA. nidula~ strain 003 at 38 mg protein per ml 
was incubated with [14C]MBC at 21.2/~M  (53.0 x  104 
dpm/ml) for 2 h at 4~  Binding  was determined with thc 
charcoal assay, in which the length of the  incubation 
period was varied. 
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MBC Binding in 48,000-g Supernatant Mycelial Extracts of Fungal Species and Strains, Which Differ in MBC 
Sensiavity 
MBC conch.  Bound MBC 
(dpra/ml) x  (dpm/ml) x  pmol/rag  pro- 
Species  Strains  IDa*  Protein conch.  10  -s  I~M  10  -~  tein 
Aspergillus nidulans 
IJM  mg/ml 
003  4.5  38  64.0  2.6  56.4  6.0 
186  1.5  42  68.2  2.7  122.0  11.5 
R  95  40  68.2  2.7  3.2  0.3 
Penicillium  brevicom-  S  <2r  22  67.0  2.7  41.4  7.6 
pactum  R  >2,000~  20  56.0  2.2  2.2  0.4 
Penicillium  corymbi-  S  <2:~  24  66.0  2.6  20.8  3.4 
ferum  R  >2,000:~  38  56.8  2.3  1.4  0.1 
Alternaria brassicae  >1,000w  37  64.0  2.6  3.7  0.4 
Pythium irregulare  >1,000w  ND  65.0  2.6  2.5  ND 
Mycelial extracts were incubated for 2 h at 4~  with ['4C]MBC.  Binding was determined by gel filtration of 1 ml of 
the incubation mixture through a Sephadex G-100 column. 
* Inhibitory concentration causing  a 50% reduction in growth on agar medium. 
~: Data from Bollen (6) for benomyl. 
w Data from Bollen and Fuchs  (7) for benomyl. 
ND, not determined. 
for MBC-sensitive fungi does not interact with in 
vitro microtubule  assembly in brain  extracts  (23, 
27, 44). 
For further work  the  three A. nidulans  strains 
003,186,  and R  were selected, merely because of 
the  fact  that  their  genetic  background  is  known 
(69,  70). 
Molecular  Weight of the MBC  Complex 
To determine the molecular weight of the MBC 
complex,  a  partially  purified  mycelial  extract, 
which had been incubated with [14C]MBC, was gel 
filtrated through a calibrated Sephadex G-200 col- 
umn.  The  bulk  of  the  bound  radioactivity  was 
eluted in a single peak and as can be seen in Fig. 3 
the elution volume corresponds  with a  molecular 
weight  of  the  MBC  complex  of  approximately 
110,000.  Since  this  value  is very similar to  that 
found for the colchicine-tubulin complex (17), the 
elution behavior of both complexes was compared 
on a  1.5  x  27-cm Sephadex G-200  column. The 
elution volume of the MBC complex appeared to 
be  similar to  that  of the colchicine-tubulin  com- 
plex. 
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FIGURE 3  Molecular  weight  determination  of  the 
MBC-protein complex.  5  ml of an  ammonium  sulfate 
fractionated (35-50%) mycelial extract (48,000 g) at 38 
mg protein per ml was  incubated with  [~4C]MBC at  8 
/xM for 2 h at 40C and gel filtrated through a calibrated 
Sephadex  G-200  column.  The  labeled  complex  was 
eluted as a single peak at an elution volume correspond- 
ing to a mol wt of -110,000. 
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The binding of MBC to its receptor was rapid 
and increased to a plateau within 15 min of incu- 
bation at 4~  Therefore an incubation  period of 1 
h or more with [14C]MBC, as routinely used in our 
experiments, can be considered to be long enough 
for maximum binding. 
MBC-binding activity was influenced by pH as 
is illustrated in Fig. 4. Maximum binding  appeared 
between pH  6.5  and 6.8.  Whether pH  affected 
binding of MBC indirectly through an effect on 
stability of the receptor or directly has not been 
investigated. 
MBC-binding activity was not stable.  At 40C 
the ability of mycelial extracts to bind MBC de- 
cayed  according to  first order  kinetics (Fig.  5). 
The half time for inactivation was 6.5 h. Sucrose, 
MBC, and glycerol stabilized the binding activity. 
Known stabilizers of colchicine-binding  activity of 
tubulin like vinblastine sulfate and GTP did not 
significantly increase the stability. 
The decay of the binding activity was enhanced 
by high temperature. Binding activity of extracts, 
which had been heated for 1 h at 37~  cooled in 
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Effect of pH on MBC binding. 2-ml samples 
of a 127,000-g (t h) supernatant mycelial extract of A. 
nidulans strain  186  at  24  mg  protein  per  ml  were 
adjusted to different pH values with 50/zl of a HaPO4 or 
KOH solution, respectively, of different strength. 1 ml of 
the resulting preparation was incubated with [14C]MBC 
at  11  /~M (27.5  x  104 dpm/ml) for  1 h at 4"C. The 
quantity of bound MBC was determined with the char- 
coal assay. The pH (22~  was determined in the other 
milliliter of the preparation. 
100  tl/2= 
sucrose  &8.1 h 
0~75 
"  NBC  21.3 h 
glycerol  18.3 h 
~5 
-6 50 
.c_ 
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FIOURE 5  Stability  of the MBC-binding activity under 
various conditions at 4"C. 3 ml of a mycelial  extract ofA. 
n/du/a~ strain 186 at 24 mg protein per ml was mixed 
with an equal volume of a solution of respectively, 1 mM 
vinhlastine sulfate (VB), 2 mM GTP, 8 M glycerol, 22.8 
/~M [t~C]MBC (56.8  x  104 dpm/ml), and 2 M sucrose 
in PKMg solution. As a control preparation a 3-ml ex- 
tract was diluted with 3 ml of PKMg solution. At the 
times indicated, [14C]MBC was added (28.4 x 104 dpm/ 
ml) to  aliquots of the  mixtures except to  that which 
already contained ['~C]MBC. After  incubation for  15 
rain at 4~  the quantity of bound MBC was determined 
with the charcoal assay using  appropriate blanks. Bind- 
ing activity  was expressed as percent of initial binding di- 
rectly after mixing the solutions (510 dpm/50 /Ll of 1:1 
diluted extract). The  half times of decay (tin)  of the 
MBC-binding activity have been calculated from  the 
slopes of the lines. 
ice  for another hour, and centrifuged to remove 
heat-denatured proteins, was 11% of that of con- 
trol samples which were kept at 4~  during heat- 
ing and centrifuging of the experimental sample. 
Since for unknown reasons the charcoal assay ap- 
plied to heated extracts gave anomalous binding 
data, binding activity was measured with the gel 
filtration method. Binding activity in the control 
sample was determined with the charcoal assay. 
Incubating mycelial extracts with 0.1% trypsin 
for 1 h at 4~  before incubation with [14C]MBC 
resulted in a 55% loss of binding capacity. 
Centrifuging at 127,000 g for 1 h at 4~  of the 
48,000-g supernate lowered the binding activity 
of the resulting supernate to 70-80% of that of 
control samples which were not centrifuged and 
were stored at 4~  for the duration of the run. 
This result suggests that the MBC-binding activ- 
ity might be partially associated with some partic- 
ulate fraction. The nature of this binding activity 
has not been studied further. 
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A. nidulans Strains 003,  186, 
and R 
Since it has been suggested (22, 23) that differ- 
ences in affinity of MBC-binding sites for MBC 
might be the biochemical basis of the selectivity 
of MBC,  we determined apparent binding con- 
stants (K) and the number of binding sites (So) in 
mycelial extracts of the three A. nidulans strains. 
Total MBC binding was measured as a function 
of free  MBC  concentration and the  data  were 
plotted in double reciprocal form (11). 
Results of a  number of experiments are sum- 
marized in Fig. 6.  From the slopes of the lines 
and  the  intercepts,  values  of So,  expressed  as 
maximum binding capacity  in picomoles MBC 
per milligram protein and the apparent binding 
constants were calculated. Evidently the number 
of binding sites in extracts of the three strains are 
about equal, but the respective binding constants 
differ considerably. The reciprocals of the bind- 
ing constants, which are identical with the MBC 
concentration which will half-maximally saturate 
the MBC-binding site, are 2.2, 0.6, and 27  /zM 
for extracts of strains 003,  186, and R, respec- 
tively. These values correspond with the inhibi- 
tory concentration of MBC causing a 50% reduc- 
tion in growth  (see Table I). This strongly sug- 
gests that the response of the three A. nidulans 
strains to MBC is governed by the affinity of the 
receptor site for MBC. 
Inhibition of MBC Binding by 
Antimitotic Agents 
To characterize the MBC-receptor site in fungi, 
several compounds which interact in some  way 
with tubulin, were tested for inhibitory effects on 
MBC binding. A  first screening was carried out 
by adding these compounds simultaneously with 
[14C]MBC at varying concentrations to mycelial 
extracts of A.  nidulans  strain 186.  Podophyllo- 
toxin and vinblastine sulfate, which compounds 
are  known to  bind to  tubulin (74,  75)  did not 
reduce MBC binding at a  concentration of 500 
/zM.  Melatonin which has been shown to inter- 
fere with colchicine binding to mammalian brain 
tubulin (76) and which was active in the Stentor 
oral migration assay for inhibitors of microtubule 
function (52),  was  also ineffective at  500  ttM. 
co 
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003  4-5(•  )xlO 5  "~ 
186  1.6 (-+-O05)xlOS ~"  8 
R  3.7(-+0.5 )xlO  4 
Maximum  bound  MBC 
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FIeURE 6  Binding of [~4C]MBC to mycelial extracts of A. nidulans, strains 003, 186, and R. Mycelial 
extracts of strains 003,186, and R at 38, 39, and 40 mg protein per mi, respectively, were incubated with 
[~4C]MBC at increasing concentrations for 1 h at 4~  The quantity of bound MBC was determined with 
the charcoal assay. The concentration of free MBC was calculated from the differences between total and 
bound MBC. Values of binding constants K (liters/mol) and maximum binding capacity (picomoles  MBC/ 
milligrams protein) with their respective standard deviations are given as determined in at least four 
experiments. 
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A. nidulans (19) and selectively interferes with in 
vitro microtubule assembly (73),  did not affect 
MBC binding at  1,000  /~M,  either when added 
simultaneously with  [*4C]MBC or after extracts 
had  been incubated for  1  h  before  incubation 
with [14C]MBC for another hour. 
Oncodazole,  which  is  more  toxic  to  the  A. 
nidulans  strains than  MBC  and to  which  com- 
pound MBC-resistant strains are  cross-resistant 
(23), appeared to be a very effective inhibitor of 
MBC binding. At 10  /~M, oncodazole inhibited 
MBC binding  for 92%, if it was added to extracts 
1 h before these were incubated with  [14C]MBC 
at 5.5 /~M for another hour. 
Colchicine,  which  did  not  inhibit  mycelial 
growth on agar of any of the three A.  nidulans 
strains at concentrations up to  10  raM,  slightly 
inhibited MBC binding at 500/,,M, when added 
simultaneously  with MBC. At 10 mM and if added 
to  extracts  1 h  before  addition of  [14C]MBC at 
11.6  /zM,  this  compound inhibited binding for 
40%. 
Both compounds inhibited MBC binding in a 
competitive manner as is illustrated in Figs. 7 and 
8.  The  long  incubation period  used  here  was 
found  necessary  to  obtain  equilibrium in  the 
binding reactions. To reduce the decay of binding 
activity during this period sucrose was added to 
the extracts. 
The  inhibition constant  (K~) for  oncodazole 
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FIGURE 7  Inhibition of MBC binding by oncodazole. A 
mycehal extract ofA. nidulans strain 186 at 33 mg protein 
per ml was diluted 1:1 with a solution of 2 M sucrose in 
PKMg buffer. Aliquots  of the solution were incubated 
with increasing  concentrations  of [14C]MBC with (0) and 
without (O) 1 p,M oncodazole for 20 h at 4~  Bound 
MBC was assayed by the charcoal  method. The concentra- 
tion  of free MBC  was  calculated from the  difference 
between total and bound MBC. 
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FIGURE 8  Inhibition of MBC binding by colchicine. A 
mycelial  extract ofA. n/du/ans strain 186 at 31 mg protein 
per ml was diluted 1:1 with a solution of 2 M sucrose in 
PKMg buffer. Aliquots of the  solution were incubated 
with increasing  concentrations  of [14C]MBC with (O) and 
without (O) 1 mM colchicine  for 20 h at 4~  Bound MBC 
was assayed by the charcoal method. The concentration  of 
free MBC was calculated from the  difference between 
total and bound MBC. 
was 0.8  x  10 -7 M. This value indicates a higher 
affinity of the MBC-binding protein for oncoda- 
zole than for MBC, which is compatible with the 
observation  that  oncodazole  showed  a  higher 
fungitoxicity than  MBC.  Oncodazole  inhibited 
the growth of strain 186 for 50% at a concentra- 
tion of 0.23 ~M. MBC achieved this at 1.5 /~M. 
The inhibition constant for colchicine was 0.4  x 
10  -3  M  indicating a  low  affinity of  the  MBC- 
binding protein for this compound. 
Since it has been shown that oncodazole and 
colchicine  bind  to  mammalian  tubulin  at  the 
same  site  (45),  competitive inhibition of MBC 
binding in mycelial extracts  by these  two  com- 
pounds indicates that  the  MBC-binding site  is 
located on fungal tubulin. 
Colchicine-Binding  Activity of 
Mycelial Extracts 
Competitive  inhibition  of  MBC  binding  to 
fungal  tubulin implies  binding of  colchicine  to 
fungal tubulin. Since reports on colchicine binding 
in fungi are rather scarce and somewhat contro- 
versial (18, 38, 43, 46, 54), the colchicine-binding 
activity of mycelial extracts  of A.  nidulans  was 
investigated. 
Preliminary experiments in which mycelial ex- 
tracts were incubated with  [aH]coichicine at  10 
/,tM, showed that up to 6% of total radioactivity 
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Since  this  amount was  unexpectedly high,  the 
nature  of  this  bound radioactivity was  investi- 
gated. Thin-layer chromatographic (TLC) analy- 
sis, with chloroform/acetone/diethylamine (5/4/ 
1) as solvent, of Sephadex  G-100 column frac- 
tions  which  contained  bound  radioactivity  re- 
vealed that the radiolabel was present in a com- 
pound X, which was not identical with colchicine. 
Furthermore, in contrast with known coichicine- 
tubulin complexes, the  complex was  perchloric 
acid (PCA) stable, because after adding PCA at a 
final concentration of 0.5 N to the fractions men- 
tioned above, and centrifuging the mixture, about 
70%  of  the  radioactivity  remained  associated 
with the pellet. Washing the pellet with ethanol/ 
ether  (3/1)  removed most of the  radiochemical, 
which was  identified as compound X  with TLC 
analysis. Since it was  presumed that  this  radio- 
chemical  was  present  as  an  impurity  in  our 
[aH]colchicine  preparation,  the  latter  was 
purified (for details see Materials and Methods) 
and  binding experiments were  performed  with 
the purified compounds. Results of these experi- 
ments are given in Table II, exps. 2 and 3. As is 
evident about 50% of the radioactivity present in 
compound X  was  bound to  components of the 
mycelial extract.  With  purified  [3H]colchicine, 
less radioactivity was bound than with the nonpu- 
rifled  preparation.  These  results  indicate  that 
binding activity of mycelial extracts upon incuba- 
tion with unpurified [aH]colchicine is mainly due 
to association of the radiochemical impurity with 
macromolecular components. 
Since  purification of  [3H]colchicine prepara- 
tions is laborious and 100% purity can never be 
achieved, in further experiments a more specific 
binding assay with DEAE-Sephadex A-50 anion 
exchanger has been used. Mycelial extracts were 
incubated with  [3H]colchicine at  500  ~M  (ap- 
proximately 19.6  x  108 dpm/ml) for 1 h at 4~ 
and  run  onto  DEAE-Sephadex  columns.  The 
elution pattern of radioactivity, which is shown in 
Fig. 9 a shows two high peaks and one very small 
peak. TLC analysis revealed that radioactivity in 
fraction 4, which contained the bulk of the pro- 
tein which was not adsorbed to the ion exchan- 
ger,  was  present in the  form  of compound X, 
whereas  radioactivity eluted  at  the  two  other 
peaks represented colchicine. The  high peak  is 
due to free colchicine since it is eluted at the bed 
volume of the column. The second [aH]colchicine 
peak was eluted at approximately 0.52 M NaCl. 
Since  colchicine-tubulin complexes  are  charac- 
teristically eluted at this ionic strength (see also 
next sections) this result suggests the formation 
of a colchicine-fungal tubulin complex in the in- 
cubation  mixture.  That  indeed  colchicine  was 
eluted as bound to protein and not in a free form 
was determined by gel filtration of an aliquot of 
fraction 27 on a Sephadex G-25 column (1.5  x 
20  cm),  immediately upon elution of this frac- 
tion. About 37% of the radioactivity recovered 
in the  eluate, eluted associated with protein in 
the void volume of the column. 
When mycelial extracts were incubated at 37~ 
for 1 h with [aH]colchicine and after centrifuging 
bound colchicine was assayed with the  DEAE- 
Sephadex method, the quantity of bound colchi- 
cine seemed to be lower than that after incuba- 
tion at 4~  (Fig. 9b). Since the binding site for 
colchicine  is  evidently  identical  with  that  of 
MBC,  which  appeared  to  be  denatured  under 
these conditions, this result would be expected. It 
should  be  further  noticed  that  no  significant 
amount  of  radioactivity  was  eluted  associated 
with the bulk of the protein. This suggests that 
compound X either did not bind at this tempera- 
TABLE II 
Binding  of [aH]Colchicine in Mycelial Extracts 
Concentration 
Bound 
Exp.  Binding  agent  ~M  dpm/ml  radioactivity*  % Bound 
dpmlml 
1  [5H]Colchicine  from stock  10  3.7 x  105  2.1  ￿  105  5.7 
2  [aH]Colchicine  purified~  ?  1.2 x  10  e  1.3 x  104  1.1 
3  [3H]X purifiedr  ?  1.3 x  105  6.7 ￿  104  52.0 
~: [sH]Colchicine  and [5H]X were purified according to the method described under Materials and Methods. 
* Bound radioactivity  was determined with the Sephadex G-100 assay after mycelial  extracts ofA. nidulatts strain 003 
at 41 mg protein per ml (exp. 1) or strain R at 42 mg protein per ml (exps. 2 and 3) had been incubated with the 
radiochemicals for 2 h at 4~ 
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FIGURE 9  DEAE-Sephadex A-50 column chromatog- 
raphy of mycelial extracts  of A.  nidulans strain  186 
incubated  with [aH]coichicine at 4~  (a) and 37~  (b) 
for  1 h.  48,000-g  supernatant  mycelial extracts  at 32 
(a)  and  29  (b)  mg  protein  per  ml  were  incubated 
with 500/zM [aH]colchicine (19  x  10  e dpm/ml (a) and 
12.2 x  10  e dpm/ml (b)). 4 mi of the incubation mixture 
(a) or supernate  of the centrifuged  incubation  mixture 
(b)  was  loaded  onto  DEAE-Sephadex  columns  and 
eluted as described under Materials and Methods.  The 
graphs  show  the elution  pattern of radioactivity.  The 
dashed line indicates the NaC1 concentration. 
ture  or  was  associated with  components  which 
were removed from the extract by centrifuging. 
These possibilities were not studied further. 
Since  the  DEAE-Sephadex-binding  assay  is 
not suitable for quantitative measurements  due 
to dissociation of the colchicine-tubulin complex 
during the procedure, no attempts were made to 
determine  in  this way the  binding constant for 
colchicine and fungal tubulin. 
Purification of Fungal Tubulin 
As has been  shown  in the preceding sections, 
the MBC-binding protein can be assumed to be 
identical with fungal tubulin. This makes MBC a 
suitable tool for the purification of fungal tubu- 
lin, analogous to the  use  of colchicine in purifi- 
cation methods for mammalian tubulin.  With a 
standard  purification procedure  for  tubulin the 
following  results  were  obtained.  MBC-binding 
activity in 48,000-g supernatant mycelial extracts 
could be selectively precipitated with ammonium 
sulfate  between  35  and  50%  saturation.  High- 
speed centrifuging and  ammonium  sulfate frac- 
tionation  together  resulted  in  a  preparation 
which contained approximately 50% of the initial 
binding activity. The specific activity of this prep- 
aration was increased about twofold. 
In previous work (22,  23) it has been shown 
that the MBC complex was retained on a DEAE- 
Sephadex  A-50  anion  exchanger  and  could  be 
selectively eluted  at  an  ionic strength  of 0.6  M 
KC1. Therefore, DEAE-Sephadex column chro- 
matography  which  has  proven  to  be  useful  in 
purification of tubulin from other organisms (cf. 
74), was included as a final purification step for 
fungal  tubulin.  This step was first standardized 
with bound [14C]MBC.  A  partially purified prep- 
aration  was  incubated  with  [14C]MBC  and  ap- 
plied to the column. Part of the elution patterns 
of  radioactivity obtained  with  preparations  of 
strains 003,186, and R are shown in Fig. 10. For 
strain 186, part of the radioactivity was eluted as 
a  distinct peak at approximately 0.52  M  NaC1, 
whereas  with  strain  003  only a  small shoulder 
was observed in  the  elution pattern  at this salt 
concentration. As expected with strain R  no sig- 
nificant amounts of radioactivity were eluted at 
NaCl concentrations of 0.4 M  and higher. 
Whether  elution  of  radioactivity at  0.52  M 
NaC1 was caused by elution of the MBC-protein 
complex itself or by dissociation of MBC  from 
the DEAE-bound complex, due to increasing salt 
concentration, was determined by rechromatog- 
raphy of the fractions concerned on Sephadex G- 
100  columns.  It  appeared  (Table  III) that  de- 
pending on the strain used, considerable amounts 
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FIGURE 10  DEAE-Sephadex A-50 column chromatog- 
raphy of partially  purified mycelial  extracts ofA. n/du/ans 
strains 003, 186, and R. 127,000-g supematant mycelial 
extracts were fractionated with a  saturated ammonium 
sulfate solution (Materials and Methods). 5 ml of the 
preparations containing 15 mg (strain 003), 12 mg (strain 
186), and 19 mg (strain R) protein per ml was incubated 
with [14C]MBC at 5.1 /zM (12.8 x  104 dpm/ml) and run 
onto DEAE-Sephadex colunms  as described under Mate- 
rials and Methods. Graphs show part of the elution pattern 
of radioactivity.  (O) strain 003; ((3) strain 186; (B) strain 
R. The dashed line indicates the NaCI concentration. 
TABLE III 
Gel Filtration  of DEAE-Purified MBC-Protein 
Complex on a Sephadex G-I O0 Column 
Strains 
003  186 
Radioactivity  of  DEAE-purified  [t4C}-  3,140  15,220 
MBC-protein complex, dpm/ral 
Recovery of bound [14C]MBC after gel ill-  701  8,410 
tration on Sephadex G-100, dpmlml 
Recovery of bound [14C]MBC,  %  22  55 
48,000-g supernatant myoelial extracts of A. nidulans strain 003 at 38 mg 
protein  per ml and of strain 186 at 37 mg protein per ml in PKMg buffer 
were incubated with p4C]MBC at 7.8 p,M (19.4 x  104 dpm/ml) and 8.1 p.M 
(20.2 x  104 dpm/ml), respectively, for 2 h at 4"C. 10 ml of the incubation 
mixture was run onto a  DEAE-Scphadex A-50 column equilibrated with 
PKMg buffer, as described under Materials and Methods, but using potas- 
sium buffers  instead  of sodium buffers. Radioactivity of the fractions was 
determined immediately after they had been eluted.  1 ml of the fraction 
containing the  peak of bound MBC  was filtered  immediately  through a 
Sephadex  G-100 column. 
of  radioactivity were  bound to  protein,  which 
indicates  the  elution  of  purified  MBC-protein 
complex from the column. 
In subsequent experiments no  [t4C]MBC  was 
present,  and  fractions  eluted  at  0.45-0.90  M 
NaCI  were  considered  to  contain the  purified 
binding protein.  The  MBC-binding activity  of 
DEAE-purified protein has not yet been investi- 
gated in detail. In a preliminary experiment, in 
which a crude mycelial extract fractionated with 
ammonium  sulfate  was  passed  through  the 
DEAE-Sephadex column and the resulting puri- 
fied  protein  solution was  concentrated  with  a 
Sartorius  ultrafiltration device  (Sartorius  Mem- 
branFilter GmbH,  G6ttingen,  West  Germany), 
approximately 5 %  of the initial binding capacity 
of the crude extract was  recovered. The specific 
activity of this  preparation was  raised  to  about 
13-fold of that of the  crude extract. This rather 
low yield indicates a considerable loss of binding 
activity during the procedure, which was probably 
due to the instability of the binding protein. 
Proteins isolated from the three strains of A. 
nidulans  by  DEAE-Sephadex  column chroma- 
tography were analyzed with the continuous SDS 
system.  Gels loaded with reduced protein sam- 
ples of fractions 24-30 (Fig. 10) from the experi- 
ment with strains 186 and R  are shown in Figs. 
11  and  12,  respectively. As reference, reduced 
porcine brain tubulin purified by one polymeriza- 
tion cycle  was  run on  a  separate  gel.  On  gels 
loaded  with  proteins  from  strain  186  three 
closely spaced bands, among others, were pres- 
FIGURE 11  Electrophoretic analysis  of proteins isolated 
from A. nidulans strain 186 by DEAE-Sephadex column 
chromatography. Samples  of fractions 24-30 (see Fig. 10, 
strain 186) were reduced and analyzed  on the continuous 
SDS system. Reduced porcine brain tubulin (T) purified 
by one polymerization  cycle was run as a reference. 
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from A. nidulans  strain R by DEAE-Sephadex column 
chromatography. Samples of fractions 24-30 (see Fig 10, 
strain R) were reduced and analyzed on the continuous 
SDS system. Reduced porcine brain tubulin (T) purified 
by one polymerization cycle was run as a reference. 
ent  which  have  a  comparable  mobility as  the 
porcine brain monomers which move together in 
this system. The banding patterns of gels loaded 
with  reduced proteins from  corresponding frac- 
tions derived from strain 003  were  very similar 
(not shown).  In gels loaded with  proteins from 
strain R, however, only one band was present at 
a  migration  distance  which  is  comparable  with 
that of brain tubulin. 
The  difference  was  more  pronounced  when 
proteins  were  reduced  and  carboxymethylated 
before  analysis  with  the  same  system.  Gels 
loaded with  DEAE-purified proteins, eluted at 
0.45-0.90 M NaCI, from strains 003,186, and R 
are  shown  in  Fig.  13a.  Carboxymethylated 
DEAE-purified porcine brain tubulin was run as 
reference protein. It is evident that the prepara- 
tion of strain R differed from those of strains 003 
and  186.  In gels loaded with proteins from  the 
latter two strains, two distinct bands are present 
with  a  comparable mobility as  the  band  repre- 
senting porcine brain tubulin and one band which 
had  moved  slightly faster.  With  strain  R,  two 
weak bands are present at this migration distance 
whereas other bands showed about equal staining 
as corresponding bands present in the other two 
gels. 
When  identical  protein  preparations  of  the 
three strains were run on discontinuous SDS gels, 
two major bands of unequal staining density were 
found with similar mobility as the bands on the 
reference gel (Fig. 13 b ). The faster moving band 
on the reference gel is due to/3-tubulin and the 
slower moving one to a-tubulin (51). 
When  gels from  both  SDS  systems are  com- 
pared  it  is  evident  that  two  bands,  which  are 
found to be separated in the continuous system, 
move together in the discontinuous system. With 
respect to  the  staining densities of the  bands  it 
seems that one of the two slower moving bands of 
the  continuous  system moves together with the 
faster moving band in the discontinuous system. 
Both  gel  systems  could  be  correlated  in  the 
following manner.  It  was  found  that  heating  a 
DEAE-purified  preparation  for  1  h  at  37~ 
cooling in ice and centrifuging, resulted in a  su- 
pernate  in  which,  upon  electrophoresis  in  the 
continuous SDS system, the  two slower moving 
bands  were  not  present  (Fig.  14a,  b).  These 
bands appeared to be present in gels loaded with 
the pelleted material. Heat-dependent precipita- 
tion of proteins was not reversible by cold, nor 
was the process inhibited by Ca  2§  colchicine, or 
MBC,  which  eliminates the  possibility that  mi- 
crotubule  assembly  is  responsible.  Apparently 
denaturation  by heat of the  proteins concerned 
causes precipitation which  is in  agreement with 
h6UP.E 13  Electrophoretic analysis of proteins isolated 
from A.  nidulans  strains  003,  186,  or R, by DEAE- 
Sephadex column chromatography. Lyophilized proteins 
from pooled fractions eluted at 0.45-0.90 M NaC1 were 
carboxymethylated and run in the continuous SDS system 
(a) and the discontinuous system (b). Carboxymethylated 
DEAE-purified  porcine brain tubulin was run as a refer- 
ence. 
L.  C.  DAVIDSE AND  W.  FLACH Differential  Binding  of MBC  to  Fungal  Tubulin  187 Fmu~  14  Electrophoretic analysis of proteins isolated from A. nidulans strain 186 by DEAE-Sephadex 
column chromatography. Pooled fractions eluted at 0.45-0.60 M NaC1 were heated for 1 h at 370C, cooled in 
ice, and centrifuged at 40,000 g for 10 rain. Aliquots of the nonheated (N), heated (H) and supernatant 
(S) protein solution, and the pellet (P) were either reduced and run in the continuous SDS system (a) or 
carboxymethylated and run in both SDS systems (b, c). DEAE-purified  porcine brain tubulin (T), either 
reduced (a) or carboxymethylated (b, c) was run as a reference. 
the observation that mycelial extracts which are 
heated at 37~  and centrifuged, show rather low 
MBC-binding activity. 
Upon electrophoresis in the discontinuous sys- 
tem the precipitated material runs mainly as two 
bands, with similar mobility as c~- and/3-tubulin 
from  porcine brain (Fig.  14c).  Because  of this 
behavior  it can  be  concluded  that  these  bands 
represent both tubulin monomers of A. nidulans. 
The third faster moving band in continuous SDS 
gels which showed a similar mobility as fl-tubulin 
in  the  discontinuous  system,  apparently  repre- 
sents a  protein which copurified with fungal tu- 
bulin in this purification procedure. 
It  is  evident  that  the  purification  procedure 
applied to extracts of strain R  resulted in signifi- 
cantly less a- and  fl-tubulin, than  was obtained 
with  a  similar procedure  applied to  extracts of 
strains 003 and 186. Although a somewhat lower 
initial tubulin concentration might be partly re- 
sponsible  (Fig.  6),  it  is  certainly  not  the  only 
factor involved. A reason for the failure to purify 
tubulin of strain R  might be a low affinity of this 
tubulin for  DEAE-Sephadex.  A  low  affinity of 
brain tubulin for DEAE-Sephadex has been re- 
ported  (47,  53)  and  seems  to  be  related  with 
phosphorylation of the protein. At any rate, the 
different behavior of tubulin of strain R  in corn- 
parison with that of both other strains, suggests 
chemical  differences of the  protein  itself or  of 
factors associated with tubulin, an idea which is 
compatible with the observation that differences 
exist in affinity of the tubulins of the three strains 
to MBC. 
The results of the electrophoretic analysis indi- 
cate that MBC might be used as an affinity label 
to  purify  fungal  tubulin  from  MBC-sensitive 
strains of A.  nidulans.  It supports the idea that 
this protein is the primary target of MBC action. 
DISCUSSION 
The MBC-binding protein in A. nidulans  is char- 
acterized by a set of properties which is unique for 
tubulin (cf.  14).  Binding activity could be selec- 
tively  fractionated  with  ammonium  sulfate  be- 
tween 35  and 50%  saturation. The MBC-protein 
complex  was  retained  on  DEAE-Sephadex  col- 
umns  and its molecular weight was estimated at 
110,000.  Binding activity was labile and could be 
stabilized by sucrose,  glycerol, and  MBC  itself. 
Binding was competitively inhibited by known in- 
hibitors of microtubule function such  as oncoda- 
zole  and  colchicine.  Electrophoretic  analysis of 
partially purified preparations of the MBC-protein 
complex,  showed  the  presence  of  proteins  with 
similar mobilities as  mammalian  tubulin  mono- 
188  THE  JOURNAL  OF  CELL  BIOLOGY ￿9  VOLUME  72,  1977 mers. On the basis of these results it can be con- 
cluded that the MBC-binding protein is identical 
with fungal tubulin. 
MBC  binding to fungal tubulin was rapid, re- 
versible, and did not require a  high temperature. 
As has  been  reported recently (45),  binding of 
oncodazole to rat brain tubulin shows similar fea- 
tures. In this respect MBC and oncodazole resem- 
ble podophyllotoxin, a compound which competes 
with colchicine for the colchicine-binding site on 
tubulin from different sources (75). However, po- 
dophyllotoxin did not inhibit MBC binding which 
suggests that fungal tubulin has no or at least a low 
affinity for this compound. 
From the  data given in Fig.  6  the  number  of 
MBC-binding sites can be determined. Assuming 
that one molecule of MBC is bound per molecule 
of tubulin, one can calculate that tubulin is 0.2- 
0.4% by weight of total protein present in myce- 
lial extracts.  This  value  resembles the  value  of 
0.6%  found for the  colcemid-binding protein in 
Saccharomyces cerevisiae (38) which proved to be 
in good correspondence with the figure of 0.36% 
calculated from  the  estimate  of the  number  of 
microtubules per nucleus. 
Although colchicine was evidently bound to tu- 
bulin of A. nidulans  the binding reaction showed 
some unusual features. The rate of complex for- 
mation seemed to be rapid and binding was not 
temperature  dependent,  which  properties are in 
contrast with those of colchicine binding to mam- 
malian tubulin (cf. 74).  Moreover, affinity of A. 
nidulans tubulin to colchicine was rather low com- 
pared  with  that  of  mammalian  tubulin.  A  low 
affinity of, presumably, tubulin from S. cerevisiae 
for colchicine has been reported by Haber et al. 
(38).  Burns  (18)  was  not  able  to  demonstrate 
colchicine binding in Schizosaccharomyces pombe 
and Jockusch (46) did not find colchicine-binding 
proteins in Physarum polycephalum.  Heath  (43) 
reported the presence of two binding components 
in Saprolegnia ferax  with a low affinity for colchi- 
cine, one of which was trichloroacetic acid (TCA) 
stable.  A  TCA-stable-binding protein  was  also 
found by Olson (54) in Allomyces moniliformis. 
However, the last two authors did not investigate 
the identity of the bound radiolabel. Since in our 
colchicine-binding experiments the formation of a 
PCA-stable-labeled complex could be ascribed to 
the presence of an impurity in our [aH]colchicine 
preparation, the results of these authors should be 
interpreted with caution. 
Low affinity of A. nidulans  tubulin for colchi- 
cine is probably partly responsible for the failure 
of this compound to inhibit mycelial growth. Cell 
membrane  permeability might  also  play  a  role 
since no effect on growth was noticed at concen- 
trations  25  times  higher  than  those  which  are 
needed  to  half-maximally  saturate  the  binding 
sites in vitro. In comparison with MBC and oncod- 
azole this ratio is rather  high,  since these  com- 
pounds gave a 50% reduction in growth already at 
concentrations two to three times higher than the 
estimated  value  of  their  respective  dissociation 
constants. 
To  our knowledge data concerning affinity of 
fungal tubulin for colchicine are restricted to those 
already mentioned. We think that low affinity is a 
characteristic property of fungal tubulin. This as- 
sumption is based on the fact that fungi are com- 
monly resistant to the antimitotic action of colchi- 
cine (cf. 42), which seems only partially caused by 
a low permeability of the cell membrane (38, 64) 
and on the fact that microtubules are supposed to 
play an  essential role  in  fungal  nuclear  division 
(34,  35).  Until now  no  suitable agent has been 
found which specifically disrupts microtubules in 
fungi  (42).  Because  of their  high  fungitoxicity, 
MBC  and  oncodazole  are  potential  candidates, 
since from both compounds it is known, that they 
induce disappearance of microtubules in mamma- 
lian cells (25-27). 
The  differential  growth  response  of  the  two 
mutant strains R and 186, in comparison with that 
of the wild-type strain 003, is probably based on a 
difference in  affinity of their tubulins for MBC. 
This  idea  is  also  supported  by  the  fact  that  no 
differences are found in uptake or detoxication of 
MBC between the various strains (24). 
Genetic analysis has  shown  that  mutations  to 
resistance and to increased sensitivity took place in 
the same gene  (69,  70).  Although it can be  as- 
sumed that this gene codes for tubulin,  this can 
only be definitely concluded when differences are 
found between the primary structures of tubulin of 
the three strains. A difference in affinity for MBC 
might also be caused by differences in post-trans- 
lational modifications of tubulin, such as phospho~ 
rylation (30,  31),  glycosylation (32),  or associa- 
tion with tau-like factors (15, 16, 72). A  different 
modification, rather than a single amino acid sub- 
stitution might  also explain the  failure to  purify 
tubulin from strain R. 
Mutation to  resistance or increased sensitivity 
did not affect growth rate nor sporulation of the 
strains  (references 22  [Fig.  1]  and  69  [Fig.  1]), 
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of microtubules. However, diploids carrying both 
mutations were not stable as was evident from in- 
creased sectoring of diploid colonies.  2 Since non- 
disjunction  of  chromosomes  is  thought  to  be 
mainly responsible for sectoring, increased sector- 
ing  indicates  improper  functioning of  microtu- 
bules. This might be caused by the presence of two 
incompatible types of tubulins in these  diploids. 
Increased sectoring has also been found in ordi- 
nary A.  nidulans  diploids when they are exposed 
to MBC at sublethal concentrations (37, 41, 49). 
Griseofulvin induces  a  similar  effect  (37,  48). 
These observations are compatible with the idea 
that binding  of MBC to tubulin interferes with the 
assembly of tubulin into microtubules. 
The action of MBC and the mechanism of re- 
sistance was only studied in detail in A. nidulans, 
but the data in Table I suggest that the mechanism 
of resistance found here might be a general type of 
resistance in fungi. Since in fungi various types of 
mitosis are found (35) it would be interesting to 
know whether resistance and sensitivity to MBC is 
related to a certain type of mitosis. 
Until now no evidence has been presented that 
resistance to other agents which bind to  tubulin 
might be caused by a similar mechanism. Resist- 
ance to compounds of this type has recently been 
discussed by Freed and Ohlsson-Wilhelm (33). A 
drug exclusion mechanism was found to operate in 
several instances. The biochemical basis of resist- 
ance which appeared to be specific to the selecting 
agent, has not yet been studied. 
Several possibilities exist to explain the selectiv- 
ity of these benzimidazole compounds in general. 
In addition to a differential uptake or metabolism, 
a different affinity of tubulin from various sources 
for a certain benzimidazole compound might play 
a role. This is illustrated by the fact that no binding 
was  found  between  porcine  brain  tubulin  and 
MBC,  although  at  identical  concentrations  of 
MBC considerable binding to fungal tubulin was 
found. A  difference in affinity between tubulins 
from different sources for a certain benzimidazole 
compound might be caused by similar factors al- 
ready discussed above. 
It is noteworthy here that despite differences in 
affinity between porcine and A. nidulans  tubulin 
to MBC, the two types are able to copolymerize in 
vitro (23, 60). Apparently, binding sites involved 
2 Van Tuyl, J.  M.,  personal communication and  own 
observation. 
in polymerization  have been highly conserved dur- 
ing evolution in contrast with the colchicine-bind- 
ing site. 
Undoubtedly, these benzimidazole compounds 
will  become  useful as  experimental tools  in the 
study  of  microtubule structure  and  function in 
cells.  Their use, however, in agriculture as fungi- 
cides and, quantitatively on a minor scale, in vet- 
erinary medicine, should be reconsidered from the 
point of view of their mechanism of action. Inter- 
ference of MBC with nuclear division in mamma- 
lian cells has been found to occur in vitro (27, 59, 
67) and in vivo (59, 67). This implies a potential 
genetic risk for man. The toxicology and genetic 
effects of benzimidazole compounds have recently 
been reviewed by Seiler (59). We agree with him 
that the use of pesticides with this type of action 
should be restricted. 
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